|
Volumn 10, Issue 6, 2000, Pages 767-786
|
Cancer chemotherapeutics - Angiogenesis agents: October 1999-March 2000
a |
Author keywords
Angiopoeitin; Angiostatin; Anti angiogenesis; Antisense oligonucleotides; Cancer; Cancer drug discovery; Endostatin; FGF; Fibronectin; Gelatinase; Glaucoma; Hypoxia; Integrin; Matrix metalloproteinase; PDGF; Plasminogen; Radiotherapy; Receptor tyrosine kinase; Review; Urokinase type plasminogen activator; VEGF; Vitronectin
|
Indexed keywords
4 DEDIMETHYLAMINOSANCYCLINE;
AMG 1470;
ANGIOGENESIS INHIBITOR;
ANGIOPOIETIN 1;
ANGIOPOIETIN 2;
ANTINEOPLASTIC AGENT;
BENZAMIDE DERIVATIVE;
BENZOFURAN DERIVATIVE;
FIBROBLAST GROWTH FACTOR;
FUMAGILLIN;
FUMAGILLOL CHLOROACETYLCARBAMATE;
INTEGRIN;
INTEGRIN RECEPTOR;
MATRIX METALLOPROTEINASE INHIBITOR;
MONOCLONAL ANTIBODY;
NAY 12 9566;
PLATELET DERIVED GROWTH FACTOR;
PROTEIN TYROSINE KINASE;
TANOMASTAT;
UNCLASSIFIED DRUG;
UROKINASE;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR;
ANGIOGENESIS;
ANIMAL CELL;
CANCER;
CANCER CHEMOTHERAPY;
DRUG STRUCTURE;
HUMAN;
HUMAN CELL;
NONHUMAN;
ONCOGENE SRC;
REVIEW;
|
EID: 0034120431
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.10.6.767 Document Type: Review |
Times cited : (10)
|
References (24)
|